Literature DB >> 24293462

Comorbidities of COPD.

Arnaud Cavaillès1, Graziella Brinchault-Rabin, Adrien Dixmier, François Goupil, Christophe Gut-Gobert, Sylvain Marchand-Adam, Jean-Claude Meurice, Hugues Morel, Christine Person-Tacnet, Christophe Leroyer, Patrice Diot.   

Abstract

By 2020, chronic obstructive pulmonary disease (COPD) will be the third cause of mortality. Extrapulmonary comorbidities influence the prognosis of patients with COPD. Tobacco smoking is a common risk factor for many comorbidities, including coronary heart disease, heart failure and lung cancer. Comorbidities such as pulmonary artery disease and malnutrition are directly caused by COPD, whereas others, such as systemic venous thromboembolism, anxiety, depression, osteoporosis, obesity, metabolic syndrome, diabetes, sleep disturbance and anaemia, have no evident physiopathological relationship with COPD. The common ground between most of these extrapulmonary manifestations is chronic systemic inflammation. All of these diseases potentiate the morbidity of COPD, leading to increased hospitalisations and healthcare costs. They can frequently cause death, independently of respiratory failure. Comorbidities make the management of COPD difficult and need to be evaluated and treated adequately.

Entities:  

Mesh:

Year:  2013        PMID: 24293462     DOI: 10.1183/09059180.00008612

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  131 in total

1.  Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease.

Authors:  Evelyn Tsantikos; Maverick Lau; Cassandra Mn Castelino; Mhairi J Maxwell; Samantha L Passey; Michelle J Hansen; Narelle E McGregor; Natalie A Sims; Daniel P Steinfort; Louis B Irving; Gary P Anderson; Margaret L Hibbs
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

2.  The association between dental health and nutritional status in chronic obstructive pulmonary disease.

Authors:  Takeshi Terashima; Shotaro Chubachi; Tatsu Matsuzaki; Takahiro Nakajima; Minako Satoh; Eri Iwami; Kyouko Yoshida; Akira Katakura; Tomoko Betsuyaku
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

Review 3.  Precision prevention: A focused response to shifting paradigms in healthcare.

Authors:  Kenneth S Ramos; Emma C Bowers; Marco A Tavera-Garcia; Irma N Ramos
Journal:  Exp Biol Med (Maywood)       Date:  2019-03

4.  Characteristics of COPD Patients Using United States Emergency Care or Hospitalization.

Authors:  Suchit D Kumbhare; Tatsiana Beiko; Susan R Wilcox; Charlie Strange
Journal:  Chronic Obstr Pulm Dis       Date:  2016-03-28

5.  Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease.

Authors:  Chi-Lu Chiang; Yu-Wen Hu; Chieh-Hung Wu; Yung-Tai Chen; Chia-Jen Liu; Yung-Hung Luo; Yuh-Min Chen; Tzeng-Ji Chen; Kang-Cheng Su; Kun-Ta Chou
Journal:  Int J Clin Oncol       Date:  2016-05-06       Impact factor: 3.402

6.  Master Autophagy Regulator Transcription Factor EB Regulates Cigarette Smoke-Induced Autophagy Impairment and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis.

Authors:  Manish Bodas; Neel Patel; David Silverberg; Kyla Walworth; Neeraj Vij
Journal:  Antioxid Redox Signal       Date:  2017-02-01       Impact factor: 8.401

7.  "High-Risk" Clinical and Inflammatory Clusters in COPD of Chinese Descent.

Authors:  Pei Yee Tiew; Fanny Wai San Ko; Jayanth Kumar Narayana; Mau Ern Poh; Huiying Xu; Han Yee Neo; Li-Cher Loh; Choo Khoon Ong; Micheál Mac Aogáin; Jessica Han Ying Tan; Nabilah Husna Kamaruddin; Gerald Jiong Hui Sim; Therese S Lapperre; Mariko Siyue Koh; David Shu Cheong Hui; John Arputhan Abisheganaden; Augustine Tee; Krasimira Tsaneva-Atanasova; Sanjay H Chotirmall
Journal:  Chest       Date:  2020-02-22       Impact factor: 9.410

8.  Chronic obstructive pulmonary disease is not a risk factor for polyneuropathy: A prospective controlled study.

Authors:  Nora A Visser; Nicolette C Notermans; Ferdinand Teding van Berkhout; Leonard H van den Berg; Alexander Fje Vrancken
Journal:  Chron Respir Dis       Date:  2016-03-15       Impact factor: 2.444

9.  Effects of centrally administered etanercept on behavior, microglia, and astrocytes in mice following a peripheral immune challenge.

Authors:  Marie Lou Camara; Frances Corrigan; Emily J Jaehne; Magdalene C Jawahar; Helen Anscomb; Bernhard T Baune
Journal:  Neuropsychopharmacology       Date:  2014-08-08       Impact factor: 7.853

Review 10.  Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease.

Authors:  Katherine J Strissel; Gerald V Denis; Barbara S Nikolajczyk
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.